Skip to main content
. 2017 Mar 31;83(7):1476–1498. doi: 10.1111/bcp.13246

Table 1.

Summary of demographics and covariates

Characteristic Placebo group 90 mg RBP‐7000 group 120 mg RBP‐7000 group
Total number (n) 112 111 114
Age (years) 42.76 ± 8.65 40.45 ± 9.42 40.41 ± 9.42
Body weight (kg) 92.61 ± 22.86 90.89 ± 18.86 88.54 ± 20.34
Body mass index (kg m −2 ) 30.97 ± 7.29 29.59 ± 5.96 29.33 ± 6.73
Waist‐to‐hip‐ratio 0.95 ± 0.09 0.95 ± 0.08 0.94 ± 0.07
Alanine transferase (ALT, U/L) 29.06 ± 20.09 29.88 ± 21.01 28.54 ± 23.58
Aspartate transferase (AST, U/L) 21.65 ± 8.5 23.14 ± 12.13 20.99 ± 8.66
Creatinine clearance (CRCL, ml min −1 ) 122.69 ± 46.91 121.91 ± 32.68 122.62 ± 39.77
Gender (% male) 81 (72.3) 93 (83.78) 84 (73.6)
Ethnicity
Not Hispanic or Latino 101 (90.1%) 104 (93.6%) 104 (91.2%)
Other 11 (9.8%) 7 (6.3%) 10 (8.7%)
Race
Black or African American 84 (75%) 79 (71.1%) 80 (70.1%)
Other 28 (25%) 32 (28.8%) 34 (29.8%)
CYP2D6 genotype metabolizer
Extensive 92 (82.1%) 98 (88.2%) 97 (85.0%)
Intermediate 8 (7.1%) 4 (3.6%) 7 (6.1%)
Poor 3 (2.6%) 1 (0.9%) 3 (2.6%)
Inconclusive 8 (7.1%) 7 (6.3%) 6 (5.2%)
Missing 1 (0.9%) 1 (0.9%) 1 (0.8%)
Dopamine D2 receptor (DRD2) genotype (rs1801028)
GG 106 (94.6%) 108 (97.2%) 113 (99.1%)
GC 5 (4.4%) 2 (1.8%) 0 (0%)
Missing 1 (0.9%) 1 (0.9%) 1 (0.9)
Serotonin 2C receptor (5‐HT2C) genotype (rs3813929)
CC 102 (91.0%) 102 (91.9%) 104 (91.2%)
CT 4 (3.6%) 4 (3.6%) 3 (2.6%)
TT 5 (4.4%) 4 (3.6%) 6 (5.2%)
Missing 1 (0.9%) 1 (0.9%) 1 (0.9%)
Serotonin 2A receptor (5‐HT2A) genotype (rs6313)
CC 44 (39.2%) 45 (40.5%) 43 (37.7%)
CT 55 (49.1%) 49 (44.1%) 48 (42.1%)
TT 12 (10.7%) 15 (13.5%) 22 (19.2%)
Inconclusive 0 (0%) 1 (0.9%) 0 (0%)
Missing 1 (0.9%) 1 (0.9%) 1 (0.9%)
Melanocortin 4 receptor (MCR4) genotype (rs17782313)
CC 9 (8.0%) 9 (8.1%) 11.4 (85.0%)
TC 48 (42.8%) 55 (49.5%) 27.1 (6.1%)
TT 54 (48.2%) 46 (41.4%) 60.5 (2.6%)
Missing 1 (0.9%) 1 (0.9%) 1 (0.9%)